Martin D. Madaus - Director at Repligen Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RGEN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Martin D. Madaus - trading volume in the past year for Repligen Corp

Holdings reported by Martin D. Madaus for Repligen Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5.59K $695K $124.38 Aug 8, 2025 Direct
Common Stock 1.8K $202K $112.13 Aug 8, 2025 By Martin D. Madaus 2011 Revocable Trust
Common Stock 11 $1.37K $124.38 Aug 8, 2025 Spouse Trust
Stock Option (Right to Buy) 1.8K May 15, 2025 Direct Common Stock

Transactions reported by Martin D. Madaus for Repligen Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.